FIRST TRUST ADVISORS LP

Position in ARGX — Argenx SE

CIK 1125816 Wheaton, IL

Position in ARGX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$94,112,988

+$15,833,840 QoQ

Shares Held

101,440

-5.4% QoQ

Ownership

0.163%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#41

of 505 holders

Holding Since

Dec 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FIRST TRUST ADVISORS LP holds $2,824,813,122 across 97 Biotechnology names. ARGX ranks #12 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	547,132	$341,158,687
2	INCY	Incyte Corp	1,587,996	$180,015,226
3	CORT	Corcept Therapeutics Inc	1,829,545	$159,078,937
4	VRTX	Vertex Pharmaceuticals Inc / Ma	289,179	$143,643,884
5	EXEL	Exelixis, Inc.	2,543,353	$138,383,836
6	ALNY	Alnylam Pharmaceuticals, Inc.	421,534	$126,894,380
7	KRYS	Krystal Biotech, Inc.	324,900	$120,755,583
8	AXSM	Axsome Therapeutics, Inc.	482,061	$117,994,070

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$94,112,988	101,440	-5.4%	Shares	Sole	2026-08-11
2026-03-31	$78,279,148	107,195	+98.9%	Shares	Sole	2026-05-13
2025-12-31	$45,328,886	53,902	-17.1%	Shares	Sole	2026-02-13
2025-09-30	$47,930,336	64,985	+10.6%	Shares	Sole	2025-11-12
2025-06-30	$32,395,199	58,770	-4.3%	Shares	Sole	2025-08-13
2025-03-31	$36,340,511	61,400	-18.6%	Shares	Sole	2025-05-14
2024-12-31	$46,376,535	75,409	-8.1%	Shares	Sole	2025-02-13
2024-09-30	$44,497,178	82,086	-12.3%	Shares	Sole	2024-11-13
2024-06-30	$40,241,423	93,576	-10.6%	Shares	Sole	2024-08-13
2024-03-31	$41,231,933	104,724	+31.3%	Shares	Sole	2024-05-13
2023-12-31	$30,349,564	79,777	-3.9%	Shares	Sole	2024-02-13
2023-09-30	$40,816,597	83,023	+508.3%	Shares	Sole	2023-11-13
2022-12-31	$5,170,271	13,648	—	Shares	Sole	2023-02-09
No filing history on record for this holder in this stock.